Sandoz Pushes Back On AMR And ‘Dysfunctional’ Antibiotics Market
Get Access Balance Right And Consider Market Reforms, Urge Senior Executives
Sandoz CEO Richard Saynor and global head of anti-infectives Ian Ball have spoken out on the threat of antimicrobial resistance and the “increasing dysfunctionality” of the market framework for antibiotics.
